Therapeutic potential of self-antigen-specific CD4+CD25+ regulatory T cells selected in vitro from a polyclonal repertoire

European Journal of Immunology

Volumn 36, Issue 4, 2006, Pages 817-827

  Fisson, Sylvain ^a,c   Djelti, Fathia ^a   Trenado, Aurélie ^a   Billiard, Fabienne ^a   Liblau, Roland ^b   Klatzmann, David ^a   Cohen, José L ^a   Salomon, Benoît L ^a  

^a CNRS   (France)

^b CHU PURPAN   (France)

^c INSERM   (France)

Author keywords

Autoimmunity; Dendritic cells; Immune regulation; Regulatory T cells; Tolerance

Indexed keywords

CD8 ANTIGEN;

ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; BYSTANDER EFFECT; CD4+ CD25+ T LYMPHOCYTE; CELL STIMULATION; CONTROLLED STUDY; DENDRITIC CELL; DIABETOGENESIS; FEMALE; IN VITRO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE PROLIFERATION; MOUSE; NATURAL SELECTION; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SPLEEN CELL;

ANIMALS; ANTIGENS, CD4; AUTOANTIGENS; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; DENDRITIC CELLS; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; IMMUNE TOLERANCE; ISLETS OF LANGERHANS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; RECEPTORS, INTERLEUKIN-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES, REGULATORY;

EID: 32644486426     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200535445     Document Type: Article

References (41)

1. Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M. and Toda, M., Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 1995. 155: 1151-1164.
2. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 2004. 22: 531-562.
3. Baecher-Allan, C. and Hafler, D. A., Suppressor T cells in human diseases. J. Exp. Med. 2004. 200: 273-276.
4. + T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J. Exp. Med. 2004. 199: 1467-1477.
5. Tang, Q., Henriksen, K. J., Bi, M., Finger, E. B., Szot, G., Ye, J., Masteller, E. L., McDevitt, H. et al., In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J. Exp. Med. 2004. 199: 1455-1465.
6. Jaeckel, E., von Boehmer, H. and Manns, M. P., Antigen-specific FoxP3-transduced T-cells can control established type 1 diabetes. Diabetes 2005. 54: 306-310.
7. + T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion. J. Exp. Med. 2004. 199: 1479-1489.
8. + T cell levels in NOD mice. Proc. Natl. Acad. Sci. USA 2002. 99: 12287-12292.
9. Klein, L., Khazaie, K. and von Boehmer, H., In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro. Proc. Natl. Acad. Sci. USA 2003. 100: 8886-8891.
10. + regulatory T cells: evidence for in vivo inhibition of effector cell proliferation. J. Immunol. 2004. 172: 6539-6544.
11. + regulatory T cells by antigen-processing dendritic cells. J. Exp. Med. 2003. 198: 235-247.
12. + regulatory cell activation and function by dendritic cells. Int. Immunol. 2004. 16: 1769-1780.
13. Vremec, D. and Shortman, K., Dendritic cell subtypes in mouse lymphoid organs: cross-correlation of surface markers, changes with incubation, and differences among thymus, spleen, and lymph nodes. J. Immunol. 1997. 159: 565-573.
14. Nakano, H., Yanagita, M. and Gunn, M. D., CD11c(+)B220(+)Gr-1(+) cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells. J. Exp. Med. 2001. 194: 1171-1178.
15. Homann, D., Jahreis, A., Wolfe, T., Hughes, A., Coon, B., van Stipdonk, M. J., Prilliman, K. R. et al., CD40L blockade prevents autoimmune diabetes by induction of bitypic NY/DC regulatory cells. Immunity 2002. 16: 403-415.
16. Cohen, J. L., Trenado, A., Vasey, D., Klatzmann, D. and Salomon, B. L., CD4(+)CD25(+) Immunoregulatory T cells: New therapeutics for graft- versus-hHost disease. J. Exp. Med. 2002. 196: 401-406.
17. + immunoregulatory T cells is antigen nonspecific. J. Immunol. 2000. 164: 183-190.
18. + naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic /suppressive state. Int. Immunol. 1998. 10: 1969-1980.
19. + T cells. Eur. J. Immunol. 1992. 22: 1013-1022.
20. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 1998. 188: 287-296.
21. Herold, K. C., Hagopian, W., Auger, J. A., Poumian-Ruiz, E., Taylor, L., Donaldson, D., Gitelman, S. E. et al., Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. N. Engl. J. Med. 2002. 346: 1692-1698.
22. Keymeulen, B., Vandemeulebroucke, E., Ziegler, A. G., Mathieu, C., Kaufman, L., Hale, G., Gorus, F. et al., Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. N. Engl. J. Med. 2005. 352: 2598-2608.
23. McDevitt, H., Specific antigen vaccination to treat autoimmune disease. Proc. Natl. Acad. Sci. USA 2004. 101 Suppl 2: 14627-14630.
24. + regulatory T cells from nonobese diabetic mice. J. Immunol. 2005. 175: 3053-3059.
25. den Haan, J. M., Lehar, S. M. and Bevan, M. J., CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo. J. Exp. Med. 2000. 192: 1685-1696.
26. + dendritic cell subset selectively endocytoses dying cells in culture and in vivo. J. Exp. Med. 2002. 195: 1289-1302.
27. Belz, G. T., Behrens, G. M., Smith, C. M., Miller, J. F., Jones, C., Lejon, K., Fathman, C. G. et al., The CD8alpha(+) dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens. J. Exp. Med. 2002. 196: 1099-1104.
28. + regulatory T cells ex vivo. Blood 2003. 102: 2180-2186.
29. + regulatory T cells induced by an agonist self-peptide. Nat. Immunol. 2001. 2: 301-306.
30. + T cell receptors. Immunity 2004. 21: 267-277.
31. Bensinger, S. J., Bandeira, A., Jordan, M. S., Caton, A. J. and Laufer, T. M., Major histocompatibility complex class II-positive cortical epithelium mediates the selection of CD4(+)25(+) immunoregulatory T cells. J. Exp. Med. 2001. 194: 427-438.
32. + T regulatory cells. J. Exp. Med. 2004. 199: 323-335.
33. van Santen, H. M., Benoist, C. and Mathis, D., Number of T reg cells that differentiate does not increase upon encounter of agonist ligand on thymic epithelial cells. J. Exp. Med. 2004. 200: 1221-1230.
34. + splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7. J. Immunol. 2002. 169: 2461-2465.
35. +T cells controlling distinct organ-specific autoimmune diseases. Proc. Natl. Acad. Sci. USA 2003. 100: 15806-15811.
36. + regulatory T cells in vivo. J. Exp. Med. 2003. 198: 249-258.
37. + regulatory T cells in the steady state. J. Exp. Med. 2003. 198: 737-746.
38. Scott, B., Liblau, R., Degermann, S., Marconi, L. A., Ogata, L., Caton, A. J., McDevitt, H. O. and Lo, D., A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity. Immunity 1994. 1: 73-83.
39. + single positive cells with a class II major histocompatibility complex-restricted receptor. J. Exp. Med. 1994. 180: 25-34.
40. Barrou, B., Bertry-Coussot, L., Morin, S., Sainz, J., Lucas, B., Bitker, M. O., Debre, P. and Lemarchand, P., Prolonged islet allograft survival by adenovirus-mediated transfer of sICAM-1/Ig immunoadhesin gene. Hum. Gene Ther. 2002. 13: 1441-1450.
41. + regulatory T cells in the periphery of T cell receptor transgenic mice tolerized to transplants. J. Immunol. 2004. 172: 6003-6010.